Ask AI
H.R. 2045

Targeting Rogue and Opaque Letters Act of 2015

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

Targeting Rogue and Opaque Letters Act of 2015

(Sec. 2) This bill directs the Federal Trade Commission (FTC), and authorizes state attorneys general, to enforce against written communications (commonly referred to as demand letters) that represent in bad faith that the recipient bears liability or owes compensation for infringing an asserted patent. The pattern or practice of sending such bad faith demand letters shall be treated as an unfair or deceptive act or practice in violation of the Federal Trade Commission Act.

The bill sets forth the types of bad faith representations, assertions of legal action, claims of a sender holding an exclusive license, compensation requests, or omissions that are considered to be unfair or deceptive.

The bill provides an affirmative defense if the sender can show that statements, representations, or omissions were mistakes made in good faith, which may be demonstrated by a preponderance of evidence that the violation was not intentional and resulted from a bona fide error notwithstanding the maintenance of procedures reasonably adapted to avoid any such error.

(Sec. 3) The bill provides the FTC with authority to enforce against violations.

(Sec. 4) The bill preempts state or local laws expressly relating to the transmission or contents of communications regarding the assertion of patent rights. But the bill shall not be contrued to limit any other state laws, including those relating to consumer protection, fraud, deception, trespass, contracts, or torts.

State attorneys general may bring civil actions in federal court to enjoin violations or obtain civil penalties for violations of this bill. The maximum civil penalty for which a person may be liable for a series of related violations is $5 million.

Placed on the Union Calendar, Calendar No. 688.

Rep. Burgess, Michael C. [R-TX-26](R-TX)Sponsor
7 cosponsors1 D6 R
7cosponsors1committees10actions1related bills5subjects
  1. CalendarsH12410

    Placed on the Union Calendar, Calendar No. 688.

  2. CommitteeH12200

    Reported by the Committee on Energy and Commerce. H. Rept. 114-877.

    Energy and Commerce Committee
  3. Committee5000

    Reported by the Committee on Energy and Commerce. H. Rept. 114-877.

    Energy and Commerce Committee
  4. Committee

    Referred to the Subcommittee on Commerce, Manufacturing, and Trade.

    Innovation, Data, and Commerce Subcommittee
  5. Committee

    Ordered to be Reported by the Yeas and Nays: 30 - 22.

    Energy and Commerce Committee
  6. Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  7. Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  8. IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  9. IntroReferralIntro-H

    Introduced in House

  10. IntroReferral1000

    Introduced in House

Dec 16, 201679

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

Targeting Rogue and Opaque Letters Act of 2015

(Sec. 2) This bill directs the Federal Trade Commission (FTC), and authorizes state attorneys general, to enforce against written communications (commonly referred to as demand letters) that represent in bad faith that the recipient bears liability or owes compensation for infringing an asserted patent. The pattern or practice of sending such bad faith demand letters shall be treated as an unfair or deceptive act or practice in violation of the Federal Trade Commission Act.

The bill sets forth the types of bad faith representations, assertions of legal action, claims of a sender holding an exclusive license, compensation requests, or omissions that are considered to be unfair or deceptive.

The bill provides an affirmative defense if the sender can show that statements, representations, or omissions were mistakes made in good faith, which may be demonstrated by a preponderance of evidence that the violation was not intentional and resulted from a bona fide error notwithstanding the maintenance of procedures reasonably adapted to avoid any such error.

(Sec. 3) The bill provides the FTC with authority to enforce against violations.

(Sec. 4) The bill preempts state or local laws expressly relating to the transmission or contents of communications regarding the assertion of patent rights. But the bill shall not be contrued to limit any other state laws, including those relating to consumer protection, fraud, deception, trespass, contracts, or torts.

State attorneys general may bring civil actions in federal court to enjoin violations or obtain civil penalties for violations of this bill. The maximum civil penalty for which a person may be liable for a series of related violations is $5 million.

Apr 28, 2015

Targeting Rogue and Opaque Letters Act of 2015

Directs the Federal Trade Commission, and authorizes state attorneys general, to enforce against written communications (commonly referred to as demand letters) that represent in bad faith that the recipient bears liability or owes compensation for infringing an asserted patent. Requires the pattern or practice of sending such bad faith demand letters to be treated as an unfair or deceptive act or practice in violation of the Federal Trade Commission Act.

Sets forth the types of bad faith representations, compensation requests, or omissions that are considered to be unfair or deceptive.

Provides an affirmative defense if the sender can show that statements, representations, or omissions were mistakes made in good faith, which may be demonstrated by a preponderance of evidence that the violation was not intentional and resulted from a bona fide error notwithstanding the maintenance of procedures reasonably adapted to avoid any such error.

Targeting Rogue and Opaque Letters Act of 2015 — Informed